These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 382338)

  • 1. [Serological diagnosis of visceral leishmaniasis (kala azar) using Crithidia sp. as an antigen (preliminary report)].
    López-Brea M
    Rev Sanid Hig Publica (Madr); 1978; 52(11-12):1543-4. PubMed ID: 382338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serologic diagnosis by indirect immunofluorescence of visceral leishmaniasis using the protozoan Crithidia sp. as an antigen].
    López-Brea M
    Rev Sanid Hig Publica (Madr); 1979; 53(7-8):1109-15. PubMed ID: 400542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serological diagnosis of visceral leishmaniasis using indirect immunofluorescence].
    López-Brea M
    Rev Clin Esp; 1983 May; 169(4):233-5. PubMed ID: 6353496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post kala-azar dermal leishmaniasis and "crithidia" serology (author's transl)].
    Madero López L; Iturriaga Matarranz R; Aparicio Meix M; López-Brea M
    An Esp Pediatr; 1982 Jan; 16(1):88-91. PubMed ID: 7044207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An easily cultured Crithidia sp. as antigen for immunofluorescence for kala-azar.
    Hedge EC; Moody AH; Ridley DS
    Trans R Soc Trop Med Hyg; 1978; 72(4):445. PubMed ID: 360503
    [No Abstract]   [Full Text] [Related]  

  • 6. Early serological diagnosis in visceral leishmaniasis using Crithidia sp. as antigen.
    Lopez-Brea M; Iturriaga R; Aparicio M
    Trans R Soc Trop Med Hyg; 1979; 73(3):348. PubMed ID: 382477
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.
    Muazzam N; Rahman KM; Miah RA; Asna SM
    Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):77-81. PubMed ID: 1303085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodiagnosis of kala-azar.
    Srivastava L
    J Commun Dis; 1985; 17(1 Suppl):83-8. PubMed ID: 3913701
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and serological follow-up in three patients with visceral leishmaniasis using Crithidia sp. as antigen.
    Lopez-Brea M
    Trans R Soc Trop Med Hyg; 1980; 74(2):283-4. PubMed ID: 6992360
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sero-epidemiological study of kala-azar in a village of Varanasi district, India.
    Kumar R; Pai K; Kumar P; Pandey HP; Sundar S
    Trop Med Int Health; 2006 Jan; 11(1):41-8. PubMed ID: 16398754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widal reaction in Kala-azar.
    Singh UK; Sinha RK; Sharma VK
    Indian Pediatr; 1995 Jun; 32(6):680-3. PubMed ID: 8613339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of fluorescent antibody indirect reactions in Chagas' disease, mucocutaneous leishmaniasis and kala-azar using various Leishmania and Trypanosoma antigens].
    Nery-Guimarães F; Lage HA; Venancio IA; Grynberg NF
    Hospital (Rio J); 1969 May; 75(5):1811-25. PubMed ID: 4979318
    [No Abstract]   [Full Text] [Related]  

  • 15. An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar.
    Choudhry A; Puri A; Guru PY; Saxena RP; Saxena KC
    J Commun Dis; 1992 Mar; 24(1):32-6. PubMed ID: 1296950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of Kala azar.
    Singh UK
    Indian Pediatr; 1999 Mar; 36(3):231-6. PubMed ID: 10713835
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.
    Alam MJ; Rahman KM; Asna SM; Muazzam N; Ahmed I; Chowdhury MZ
    Bangladesh Med Res Counc Bull; 1996 Apr; 22(1):27-32. PubMed ID: 9037842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive management of Indian visceral leishmaniasis: clinical application of diagnosis by K39 antigen strip testing at a kala-azar referral unit.
    Sundar S; Sahu M; Mehta H; Gupta A; Kohli U; Rai M; Berman JD; Murray HW
    Clin Infect Dis; 2002 Sep; 35(5):581-6. PubMed ID: 12173133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.